What are the major opportunities in the Neurological Disorder Diagnostics market? What are the strategies for the Neurological Disorder Diagnostics market?

For detailed insights on the major opportunities and strategies in the Neurological Disorder Diagnostics market, Read More

How does the Neurological Disorder Diagnostics market relate to the overall economy and other similar markets?

For detailed insights on Neurological Disorder Diagnostics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neurological Disorder Diagnostics market growth? SWOT analysis of the Neurological Disorder Diagnostics market.

For detailed insights on the key dynamics influencing the Neurological Disorder Diagnostics market growth and SWOT analysis of the Neurological Disorder Diagnostics industry, Read More

Neurological Disorder Diagnostics Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neurological Disorder Diagnostics Market Report 2026

Name: Neurological Disorder Diagnostics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Component (Instruments, Reagents, Kits, Software, Services), By Technology (Immunoassay, Polymerase Chain Reaction (PCR) Techniques), By Disease Type (Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types), By End User (Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Neurological Disorder Diagnostics Market Overview

• Neurological Disorder Diagnostics market size has reached to $12.61 billion in 2025

• Expected to grow to $17.75 billion in 2030 at a compound annual growth rate (CAGR) of 7%

• Growth Driver: Rising Alzheimer's Prevalence Fuels Growth in Neurological Disorder Diagnostics Market

• Market Trend: Innovative Neurological Disease Quantification Software Transforming Diagnostics Worldwide

• North America was the largest region in 2025.

What Is Covered Under Neurological Disorder Diagnostics Market?

Neurological disorder diagnostics refer to the various methods and technologies used to identify, assess, and monitor diseases affecting the nervous system, including the brain, spinal cord, and nerves. These diagnostics involve advanced imaging techniques, biomarker analysis, genetic testing, and cognitive assessments to detect abnormalities, determine disease presence and progression, and guide treatment strategies for neurological conditions.

The main components in the neurological disorder diagnostics market are instruments, reagents, kits, software, and services. Instruments refer to the physical devices used in diagnosing neurological disorders. The various technologies include immunoassay and polymerase chain reaction (PCR) techniques, and several types of diseases including Alzheimer’s disease, dementia, Parkinson’s disease, epilepsy, traumatic brain injury, and others. The different end users encompass hospitals and clinics, diagnostic centers, and academic and research institutes.

Neurological Disorder Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Neurological Disorder Diagnostics Market Size and Share 2026?

The neurological disorder diagnostics market size has grown strongly in recent years. It will grow from $12.61 billion in 2025 to $13.54 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing prevalence of neurological disorders, rising awareness of early diagnosis importance, expansion of advanced imaging infrastructure, growing research funding for neurology, improved availability of diagnostic instruments.

What Is The Neurological Disorder Diagnostics Market Growth Forecast?

The neurological disorder diagnostics market size is expected to see strong growth in the next few years. It will grow to $17.75 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing adoption of precision neurology approaches, rising investments in digital diagnostics platforms, expansion of personalized treatment planning, growing use of tele-neurology services, advancements in neuroinformatics and analytics. Major trends in the forecast period include increasing adoption of AI-assisted neuroimaging tools, rising use of biomarker-based diagnostic kits, growing integration of genetic and molecular testing, expansion of remote and digital cognitive assessments, enhanced focus on early disease detection.

Book your 30 minutes free consultation with our research experts

Global Neurological Disorder Diagnostics Market Segmentation

1) By Component: Instruments, Reagents, Kits, Software, Services

2) By Technology: Immunoassay, Polymerase Chain Reaction (PCR) Techniques

3) By Disease Type: Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types

4) By End User: Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

Subsegments:

1) By Instruments: Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices,

2) By Reagents: Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents

3) By Kits: Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders

4) By Software: Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software

5) By Services: Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services

What Is The Driver Of The Neurological Disorder Diagnostics Market?

The increasing prevalence of Alzheimer's disease is expected to propel the growth of the neurological disorder diagnostics market going forward. Alzheimer's disease refers to a progressive neurodegenerative disorder characterized by a gradual decline in cognitive functions, including memory, reasoning, and problem-solving. Alzheimer's disease combines genetic factors, such as specific gene mutations and variations, the accumulation of amyloid plaques and tau tangles in the brain, chronic inflammation, vascular issues, and lifestyle factors. Neurological disorder diagnostics help Alzheimer's disease by enabling early and accurate detection through advanced imaging techniques, biomarker analysis, and cognitive assessments. For instance, in September 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2023, approximately 411,100 individuals in Australia were living with dementia, including around 257,500 women and 153,700 men. Thus, the increasing prevalence of Alzheimer's disease is driving the growth of the neurological disorder diagnostics industry.

Key Players In The Global Neurological Disorder Diagnostics Market

Major companies operating in the neurological disorder diagnostics market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation

Global Neurological Disorder Diagnostics Market Trends and Insights

Major companies operating in the neurological disorder diagnostics market are focused on developing innovative solutions, such as neurological disease quantification software, for one billion individuals affected by neurological diseases worldwide. Neurological disease quantification software is a tool used to measure and analyze brain function and disease progression in neurological conditions. For instance, in January 2024, Quibim, a Spain-based biotechnology company, launched the QP-Brain, an AI-based early-stage neurological disease quantification software. QP-Brain by Quibim is advanced neuroimaging analysis software designed to quantify brain tissue alterations in neurological diseases. Its unique features include AI-powered automated segmentation and detailed volumetric analysis, offering precise insights into brain structure changes for clinical and research applications.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurological Disorder Diagnostics Market?

In February 2023, Lantheus, a US-based pharmaceutical manufacturing company, acquired Cerveau Technologies for an undisclosed amount. Lantheus' acquisition of Cerveau and its tau-targeting PET imaging agent MK-6240 significantly enhances the ability to diagnose, stage, and monitor Alzheimer's disease while supporting the development of new treatments. Cerveau Technologies is a US-based company specializing in developing diagnostic technologies for neurological disorders, mainly focusing on neurodegenerative diseases such as Alzheimer's.

Regional Outlook

North America was the largest region in the neurological disorder diagnostics market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurological Disorder Diagnostics Market?

The neurological disorder diagnostics market consists of revenues earned by entities by providing services such as neuroimaging, electrophysiological testing, genetic analysis, cerebrospinal fluid examination, neuropsychological assessments, and laboratory tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurological disorder diagnostics market also includes sales of imaging devices, biomarker tests, and cognitive assessment tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurological Disorder Diagnostics Market Report 2026?

The neurological disorder diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurological disorder diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neurological Disorder Diagnostics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$13.54 billion
Revenue Forecast In 2035	$17.75 billion
Growth Rate	CAGR of 7.3% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Component, Technology, Disease Type, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neurological Disorder Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neurological Disorder Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neurological Disorder Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neurological Disorder Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Ai-Assisted Neuroimaging Tools

4.2.2 Rising Use Of Biomarker-Based Diagnostic Kits

4.2.3 Growing Integration Of Genetic And Molecular Testing

4.2.4 Expansion Of Remote And Digital Cognitive Assessments

4.2.5 Enhanced Focus On Early Disease Detection

5. Neurological Disorder Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Diagnostic Centers

5.3 Academic And Research Institutes

5.4 Neurology Specialty Clinics

5.5 Reference Laboratories

6. Neurological Disorder Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurological Disorder Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neurological Disorder Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neurological Disorder Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neurological Disorder Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neurological Disorder Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurological Disorder Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurological Disorder Diagnostics Market Segmentation

9.1. Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Reagents, Kits, Software, Services

9.2. Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Immunoassay, Polymerase Chain Reaction (PCR) Techniques

9.3. Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Alzheimer's Disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Other Disease Types

9.4. Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Diagnostic Centers, Academic And Research Institutes

9.5. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Electroencephalography (EEG) Machines, Magnetic Resonance Imaging (MRI) Machines, Computed Tomography (CT) Scanners, Positron Emission Tomography (PET) Scanners, Lumbar Puncture Equipment, Ultrasound Devices, Neurostimulation Devices, Transcranial Magnetic Stimulation (TMS) Devices

9.6. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biochemical Reagents, Antibodies, DNA Probes, RNA Probes, Enzyme-linked Immunosorbent Assay (ELISA) Reagents, Polymerase Chain Reaction (PCR) Reagents, Sample Collection Reagents

9.7. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Test Kits, Genetic Testing Kits, Biomarker Detection Kits, Immunoassay Kits, Point-of-Care Testing Kits, Screening Kits for Neurological Disorders

9.8. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Software for Imaging Analysis, Data Management Software, Clinical Decision Support Software, Patient Management Software, Laboratory Information Management Systems (LIMS), Neuroinformatics Software, Telemedicine Software

9.9. Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Testing Services, Consultation Services, Training and Support Services, Maintenance and Repair Services for Equipment, Telehealth Services, Data Analysis Services, Research and Development Services

10. Neurological Disorder Diagnostics Market Regional And Country Analysis

10.1. Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurological Disorder Diagnostics Market

11.1. Asia-Pacific Neurological Disorder Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurological Disorder Diagnostics Market

12.1. China Neurological Disorder Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurological Disorder Diagnostics Market

13.1. India Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurological Disorder Diagnostics Market

14.1. Japan Neurological Disorder Diagnostics Market Overview

14.2. Japan Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurological Disorder Diagnostics Market

15.1. Australia Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurological Disorder Diagnostics Market

16.1. Indonesia Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurological Disorder Diagnostics Market

17.1. South Korea Neurological Disorder Diagnostics Market Overview

17.2. South Korea Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurological Disorder Diagnostics Market

18.1. Taiwan Neurological Disorder Diagnostics Market Overview

18.2. Taiwan Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurological Disorder Diagnostics Market

19.1. South East Asia Neurological Disorder Diagnostics Market Overview

19.2. South East Asia Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurological Disorder Diagnostics Market

20.1. Western Europe Neurological Disorder Diagnostics Market Overview

20.2. Western Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurological Disorder Diagnostics Market

21.1. UK Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurological Disorder Diagnostics Market

22.1. Germany Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurological Disorder Diagnostics Market

23.1. France Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurological Disorder Diagnostics Market

24.1. Italy Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurological Disorder Diagnostics Market

25.1. Spain Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurological Disorder Diagnostics Market

26.1. Eastern Europe Neurological Disorder Diagnostics Market Overview

26.2. Eastern Europe Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurological Disorder Diagnostics Market

27.1. Russia Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurological Disorder Diagnostics Market

28.1. North America Neurological Disorder Diagnostics Market Overview

28.2. North America Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurological Disorder Diagnostics Market

29.1. USA Neurological Disorder Diagnostics Market Overview

29.2. USA Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurological Disorder Diagnostics Market

30.1. Canada Neurological Disorder Diagnostics Market Overview

30.2. Canada Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurological Disorder Diagnostics Market

31.1. South America Neurological Disorder Diagnostics Market Overview

31.2. South America Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurological Disorder Diagnostics Market

32.1. Brazil Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurological Disorder Diagnostics Market

33.1. Middle East Neurological Disorder Diagnostics Market Overview

33.2. Middle East Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurological Disorder Diagnostics Market

34.1. Africa Neurological Disorder Diagnostics Market Overview

34.2. Africa Neurological Disorder Diagnostics Market, Segmentation By Component, Segmentation By Technology, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurological Disorder Diagnostics Market Regulatory and Investment Landscape

36. Neurological Disorder Diagnostics Market Competitive Landscape And Company Profiles

36.1. Neurological Disorder Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neurological Disorder Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neurological Disorder Diagnostics Market Company Profiles

36.3.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Neurological Disorder Diagnostics Market Other Major And Innovative Companies

Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co. Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC

38. Global Neurological Disorder Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurological Disorder Diagnostics Market

40. Neurological Disorder Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Neurological Disorder Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Neurological Disorder Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Neurological Disorder Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neurological Disorder Diagnostics Market, Overview Of Key Products - Product Examples

Table 2: Global Neurological Disorder Diagnostics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neurological Disorder Diagnostics Market, Supply Chain Analysis

Table 4: Global Neurological Disorder Diagnostics Market, Major Raw Material Providers

Table 5: Global Neurological Disorder Diagnostics Market, Major Resource Providers

Table 6: Global Neurological Disorder Diagnostics Market, Major Manufacturers (Suppliers)

Table 7: Global Neurological Disorder Diagnostics Market, Major Distributors And Channel Partners

Table 8: Global Neurological Disorder Diagnostics Market, Key Technologies & Future Trends

Table 9: Global Neurological Disorder Diagnostics Market, Major Trends

Table 10: Global Neurological Disorder Diagnostics Market, Major End Users

Table 11: Global Neurological Disorder Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neurological Disorder Diagnostics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neurological Disorder Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neurological Disorder Diagnostics Market - TAM, US$ Billion, 2025

Table 15: Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Neurological Disorder Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Neurological Disorder Diagnostics Market - Company Scoring Matrix

Table 100: Johnson & Johnson Services Inc. Financial Performance

Table 101: F. Hoffmann-La Roche Ltd Financial Performance

Table 102: Thermo Fisher Scientific Inc. Financial Performance

Table 103: Abbott Laboratories Financial Performance

Table 104: Novartis AG Financial Performance

Table 105: Global Neurological Disorder Diagnostics Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Neurological Disorder Diagnostics Market, Competitive Dashboard

Table 107: Global Neurological Disorder Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

Table 109: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 110: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

List Of Figures

Figure 1: Global Neurological Disorder Diagnostics Market, Overview Of Key Products - Product Examples

Figure 2: Global Neurological Disorder Diagnostics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neurological Disorder Diagnostics Market, Supply Chain Analysis

Figure 4: Global Neurological Disorder Diagnostics Market, Major Raw Material Providers

Figure 5: Global Neurological Disorder Diagnostics Market, Major Resource Providers

Figure 6: Global Neurological Disorder Diagnostics Market, Major Manufacturers (Suppliers)

Figure 7: Global Neurological Disorder Diagnostics Market, Major Distributors And Channel Partners

Figure 8: Global Neurological Disorder Diagnostics Market, Key Technologies & Future Trends

Figure 9: Global Neurological Disorder Diagnostics Market, Major Trends

Figure 10: Global Neurological Disorder Diagnostics Market, Major End Users

Figure 11: Global Neurological Disorder Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neurological Disorder Diagnostics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neurological Disorder Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neurological Disorder Diagnostics Market - TAM, US$ Billion, 2025

Figure 15: Global Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neurological Disorder Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Neurological Disorder Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Neurological Disorder Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Neurological Disorder Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Neurological Disorder Diagnostics Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Neurological Disorder Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Neurological Disorder Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Neurological Disorder Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Neurological Disorder Diagnostics Market - Company Scoring Matrix

Figure 100: Johnson & Johnson Services Inc. Financial Performance

Figure 101: F. Hoffmann-La Roche Ltd Financial Performance

Figure 102: Thermo Fisher Scientific Inc. Financial Performance

Figure 103: Abbott Laboratories Financial Performance

Figure 104: Novartis AG Financial Performance

Figure 105: Global Neurological Disorder Diagnostics Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Neurological Disorder Diagnostics Market, Competitive Dashboard

Figure 107: Global Neurological Disorder Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Component, 2025 – 2030

Figure 109: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 110: Global, Neurological Disorder Diagnostics Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Interventional Neurology Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (Aneurysm Coiling And Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support ...

Neuroprosthetics Market Report 2026 - Global Outlook – By Type (Motor Neuroprosthetics, Auditory Neuroprosthetics Or Cochlear implants, Visual Neuroprosthetics Or Retinal implants, Cognitive Neuroprosthetics ), By Techni...

Neuroscience Antibodies & Assays Market Report 2026 - Global Outlook – By Product (Consumables, Instruments), By Technology (Molecular Diagnostics, Immunoassays Or Immunochemistry, Other Technologies), By Application (In...

Neuroscience Market Report 2026 - Global Outlook – By Type (Neuro-Microscopy, Electrophysiology Technologies, Neuro-Cellular Manipulation, Whole Brain Imaging, Other Types), By Service (Instruments And Consumables, Softw...

Intraoperative Neuromonitoring Market Report 2026 - Global Outlook – By Products And Services (Systems, Accessories, Services), By Modality (Motor Evoked Potentials, Somatosensory Evoked Potentials, Electroencephalograph...

Diabetic Neuropathy Market Report 2026 - Global Outlook – By Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), By Drug Class (Analgesics, Anti-Depressants, Anti-Convulsants, O...

Neurotechnology Market Report 2026 - Global Outlook – By Conditions (Cognitive Disorders, Pain Treatment, Urinary And Fecal Incontinence, Epilepsy, Parkinson's Disease, Hearing Conditions, Sleep Disorder, Depression, Oth...

Frequently Asked Questions

How big is the Neurological Disorder Diagnostics Market?

The Neurological Disorder Diagnostics market was valued at $12.61 billion in 2025, increased to $13.54 billion in 2026, and is projected to reach $17.75 billion by 2030.

What is the Neurological Disorder Diagnostics market growth?

The global Neurological Disorder Diagnostics market is expected to grow at a CAGR of 7.0% from 2026 to 2035 to reach $17.75 billion by 2035.

Who are the key players in Neurological Disorder Diagnostics market?

Some Key Players in the Neurological Disorder Diagnostics market Include, Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Medtronic plc, Amgen Inc., Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Otsuka Pharmaceutical Co. Ltd., Boston Scientific Corporation, Neurocrine Biosciences Inc., Neusoft Medical Systems Co.Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Esaote S.p.A, Canon Medical Systems Corporation, NeuroPace Inc., Lifelines Neuro Company LLC, York Instruments Ltd., Advanced Brain Monitoring Inc., Neurometrix Inc., Croton Healthcare Private Limited, NeuroLogica Corporation .

What is the anticipated growth trend for the Neurological Disorder Diagnostics market?

Major trend in this market includes: Innovative Neurological Disease Quantification Software Transforming Diagnostics Worldwide. For further insights on this market. request a sample here

Which region has the most growth potential in the Neurological Disorder Diagnostics market?

North America was the largest region in the neurological disorder diagnostics market in 2025. The regions covered in the neurological disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.